CymitQuimica logo

(22S,23S)-28-Homo brassinolide

CAS:

Ref. 3D-FH23837

25mg
282.00€
50mg
423.00€
100mg
661.00€
250mg
1,262.00€
500mg
1,675.00€
(22S,23S)-28-Homo brassinolide
Biosynth

Product Information

Name:(22S,23S)-28-Homo brassinolide
Synonyms:
  • (1R,3αS,3βS,6αS,8S,9R,10αR,10βS,12αS)-1-[(1S,2S,3S,4S)-4-Ethyl-2 ,3-dihydroxy-1,5-dimethylhexyl]hexadecahydro-8,9-dihydroxy-10α,12α-d imethyl-6H-benz[c]indeno[5,4-e]oxepin-6-oneIsohomobrassinolideBR 120
Brand:Biosynth
Description:(22S,23S)-28-Homo brassinolide is a synthetic brassinosteroid that has been shown to have growth-promoting activity in the plant. It is synthesized by the reaction of tetroxide and 28-homobrassinolide. The structure of (22S,23S)-28-Homo brassinolide is stereoselective, with an R configuration at C2 and a S configuration at C3. The hydrogen atoms at C2 and C3 are involved in hydrogen bonds with other molecules. (22S,23S)-28-Homo brassinolide exhibits a conformation that differs from 24-epibrassinolide because it does not contain an intramolecular hydrogen bond between the two rings. This synthetic brassinosteroid also has anti-inflammatory effects due to its ability to inhibit prostaglandins.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:494.7 g/mol
Formula:C29H50O6
Color/Form:Powder

Technical inquiry about: (22S,23S)-28-Homo brassinolide

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.